Answers are grounded in this paper and cite their sources.
Increased funding addresses HCV elimination targets in vulnerable communities, suggesting strategic partnerships enhance care delivery.
Increased funding for hepatitis C virus (HCV) research and care delivery is needed to support effective programs for vulnerable communities and meet the WHO 2030 targets for HCV elimination. Strategic collaborations among industry and non-industry stakeholders can address this need. Establishing clear expectations, transparency, and investigator independence in these partnerships can enhance and accelerate HCV elimination efforts. Similar collaborative partnerships can be extended to address challenges in other therapeutic areas.
No takes yet. Share an insight, caveat, or question.
Reau et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: